ATE395423T1 - Eine molekulare schaltung zur regulierung der genepression in säugetieren - Google Patents

Eine molekulare schaltung zur regulierung der genepression in säugetieren

Info

Publication number
ATE395423T1
ATE395423T1 AT00984041T AT00984041T ATE395423T1 AT E395423 T1 ATE395423 T1 AT E395423T1 AT 00984041 T AT00984041 T AT 00984041T AT 00984041 T AT00984041 T AT 00984041T AT E395423 T1 ATE395423 T1 AT E395423T1
Authority
AT
Austria
Prior art keywords
expression
mammals
region
disclosed
regulating gene
Prior art date
Application number
AT00984041T
Other languages
English (en)
Inventor
Keith A Dr Webster
Original Assignee
Keith A Dr Webster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keith A Dr Webster filed Critical Keith A Dr Webster
Application granted granted Critical
Publication of ATE395423T1 publication Critical patent/ATE395423T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
AT00984041T 1999-12-23 2000-12-15 Eine molekulare schaltung zur regulierung der genepression in säugetieren ATE395423T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17159799P 1999-12-23 1999-12-23
US09/723,326 US6893867B1 (en) 1999-12-23 2000-11-28 Molecular switch for regulating mammalian gene expression

Publications (1)

Publication Number Publication Date
ATE395423T1 true ATE395423T1 (de) 2008-05-15

Family

ID=26867243

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00984041T ATE395423T1 (de) 1999-12-23 2000-12-15 Eine molekulare schaltung zur regulierung der genepression in säugetieren

Country Status (7)

Country Link
US (2) US6893867B1 (de)
EP (1) EP1242592B1 (de)
JP (1) JP4774493B2 (de)
AT (1) ATE395423T1 (de)
CA (1) CA2394174A1 (de)
DE (1) DE60038897D1 (de)
WO (1) WO2001048187A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6893867B1 (en) * 1999-12-23 2005-05-17 Keith A. Webster Molecular switch for regulating mammalian gene expression
EP2494044A4 (de) 2009-10-30 2013-03-06 Univ Miami Hypoxiegesteuerte und bedingt ausgeschaltete angiogene aav-expressionsinduktoren
WO2011071632A2 (en) * 2009-11-09 2011-06-16 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Modified insm1-promoter for neuroendocrine tumor therapy and diagnostics
WO2012064920A1 (en) * 2010-11-11 2012-05-18 University Of Miami Methods, compositions, cells, and kits for treating ischemic injury
WO2016110518A1 (en) 2015-01-07 2016-07-14 Universitat Autònoma De Barcelona Single-vector gene construct comprising insulin and glucokinase genes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763217A (en) 1993-11-10 1998-06-09 University Of British Columbia Method of using, process of preparing and composition comprising recombinant herpesvirus vectors
GB9402857D0 (en) 1994-02-15 1994-04-06 Isis Innovation Targeting gene therapy
US5834306A (en) 1994-12-23 1998-11-10 Sri International Tissue specific hypoxia regulated therapeutic constructs
US5882914A (en) 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1
US5681706A (en) 1996-03-01 1997-10-28 Health Research Inc. Mammalian anoxia-responsive regulatory element
EP0894853A1 (de) 1997-07-24 1999-02-03 Gesellschaft für Biotechnologische Forschung mbH (GBF) Transkriptions-Silencer Protein NRF, diese kodierende Nukleinsäure und deren Verwendung
US6495130B1 (en) * 1998-12-30 2002-12-17 Calydon, Inc. Target cell-specific adenoviral vectors containing E3 and methods of use thereof
US6893867B1 (en) * 1999-12-23 2005-05-17 Keith A. Webster Molecular switch for regulating mammalian gene expression

Also Published As

Publication number Publication date
US20050266549A1 (en) 2005-12-01
US6893867B1 (en) 2005-05-17
JP2003523182A (ja) 2003-08-05
EP1242592B1 (de) 2008-05-14
WO2001048187A2 (en) 2001-07-05
WO2001048187A9 (en) 2002-11-07
JP4774493B2 (ja) 2011-09-14
EP1242592A2 (de) 2002-09-25
DE60038897D1 (de) 2008-06-26
WO2001048187A3 (en) 2002-05-30
CA2394174A1 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
Stocks et al. Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM
Ten Hagen et al. Cloning and characterization of a ninth member of the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase family, ppGaNTase-T9
GB9703146D0 (en) Methods and means for gene silencing in transgenic plants
AR059554A1 (es) Acido nucleico derivado de perkinsus marinus que codifica una 9-elongasa, delta 8-desaturasa y delta 5-desaturasa"
WO2004070016A3 (en) System for expression of genes in plants
WO2004065613A3 (en) Inducible small interfering rna (sirna) expression constructs for targeted gene silencing
ES2180641T3 (es) Inhibicion citoplasmica de la expresion genetica.
DE60234824D1 (de) Induzierbares expressionssystem in eukaryotischen zellen
AU2001255261A1 (en) Transcription factor stress-related proteins and methods of use in plants
NZ333998A (en) Method for reducing expression variability of transgenes in plant cells using DNA constructs comprising insulator elements
KR960700344A (ko) 유전자 전환성 식물내 재조합 전령 rna의 비루스성 증식방법(viral amplification of recombinant messenger rna in transgenic plants)
ATE395423T1 (de) Eine molekulare schaltung zur regulierung der genepression in säugetieren
CA2647264A1 (en) Pathogen-inducible synthetic promoter for plant expression
Kim et al. Improvement of recombinant hGM-CSF production by suppression of cysteine proteinase gene expression using RNA interference in a transgenic rice culture
ATE517997T1 (de) Promoter spezifisch für stomata schliesszellen
WO2002059336A3 (en) Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
DK0528932T3 (da) Protein associeret med akut pancreatitis og midler til diagnose af akut pancreatitis
Xu et al. USP18 restricts PRRSV growth through alteration of nuclear translocation of NF-κB p65 and p50 in MARC-145 cells
BR0210452A (pt) Gene sd1 envolvido em seminanismo em planta e usos deste
Wu et al. tRNA‐like structures and their functions
DK1045901T3 (da) Ribozymale nucleinsyrer, der spalter CCR5 eller CXCR4
Liu et al. A new splice variant of the major subunit of human asialoglycoprotein receptor encodes a secreted form in hepatocytes
Zhang et al. Recent advances in inhibition of porcine reproductive and respiratory syndrome virus through targeting CD163
Chen et al. The functional roles of the cis-acting elements in Bamboo mosaic virus RNA genome
CA2292897A1 (en) Recombinant construct for enhancement of gene expression in plants

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties